Abstract: In addition to the prototypic amyloid-b (Ab)p eptides Ab 1-40 and Ab 1-42 ,s everalA b variants differing in their amino andc arboxyt erminih ave been described. Synthetic availability of an Ab variant is often the key to study its role under physiological or pathological conditions. Herein, we report ap rotocol for the efficient solid-phase peptides ynthesis of the N-terminallye longatedA b-peptides Ab À3-38 , Ab À3-40 ,a nd Ab À3-42 .B iophysical characterization by NMR spectroscopy,C Ds pectroscopy,a na ggregation assay,a nd electron microscopy revealed that all three peptides were prone to aggregation into amyloid fibrils. Immunoprecipitation, followed by mass spectrometry,i ndicated that Ab À3-38 and Ab À3-40 are generated by transfected cellse ven in the presence of at ripartite b-site amyloid precursor protein cleaving enzyme1(BACE1)i nhibitor.T he elongated Ab peptides starting at Val(À3) can be separatedf rom N-terminallytruncated Ab forms by high-resolution isoelectric-focusing techniques, despite virtually identical isoelectricp oints. The synthetic Ab variants and the methods presentedh ere are providing tools to advance our understanding of the potential roles of N-terminallye longated Ab variantsi nA lzheimer's disease.
Introduction
Brain deposition of amyloid-b (Ab)p eptides into neuritic plaques is one of the classical neuropathological hallmarks of Alzheimer's disease (AD).
[1] Ab peptides are generated under physiological conditions by consecutive proteolytic cleavages of the amyloid precursor protein (APP) by so-called b-a nd gsecretases.
[2] Aw ell-known "non-amyloidogenic" APP processing pathwayi nvolves cleavage within the Ab-sequence by asecretase. [3, 4] Recently,further cellular APP processing pathways involving h-a nd d-secretases, both cleaving full length APP Nterminally to the b-secretase cleavage site, were reported. [5, 6] Ac onsiderable number of Ab variants differing in the exact length of their aminoand carboxy termini have been identified in amyloid plaques, [7] in blood plasma, [8] and in the cerebrospinal fluid (CSF). [9] In particular, Ab peptides ending at Ala(42) (Ab 42 ) [10, 11] and N-terminally truncated Ab peptides starting with Glu(3), post-translationally cyclizedi nto pyroglutamica cid (N3pE), [12, 13] or Phe(4) are highly abundant in the parenchymal amyloid plaques in AD brain.
[1] Well documented andw idely accepted biomarkers of cerebral Ab accumulation, which have been incorporated into updated recommendations on diagnostic guidelines for Alzheimer's disease, are increased tracer signals on amyloid positrone mission tomography (PET) imaging and low levels of soluble Ab 42 in the CSF. [14] Recently,t he concentration ratio of the Ab peptides APP669-711/Ab 1-42 in blood plasma, asm easured by immunoprecipitationf ollowed by mass spectrometry,w as reported to be strongly and positively correlated with amyloid PET. [15] Av alidated and reliable biochemical AD-surrogateb iomarker in blood would be highly advantageous for clinical routine, in particular since bloodi s much easier accessible than the CSF.T he peptideA PP669-711 (APP770 numbering) referst oa nA b 40 peptides tarting 3r esidues upstream of the "classical" Ab sequence, that begins with Asp(1). We thus refer to this peptide as Ab À3-40 .T he source of Ab À3-40 in blood is currently unknown, neither is its role under physiological or pathological conditions. In cell culture supernatants of the Chinese hamster ovary cell line 7PA2, transfected with mutant APP751 (Val-Phe7 17), Ab À3-40 wasr eported to be increased on inhibition of the b-site APP-cleaving enzyme 1( BACE1), suggesting that it results from an APP-processing pathway independento fB ACE1. [16] Herein, we describe the solid-phase synthesis of the three N-terminally elongated Ab peptides Ab À3-38 (1), Ab À3-40 (2) , and Ab À3-42 (3)( Ta ble 1). We also present ac omprehensive biophysical characterization of the N-terminally elongated peptides addressing peptidec onformations and their aggregation into b-sheet-enriched amyloid fibrils in vitro. Moreover,w eh ave identified Ab À3-40 (2)t o represent one of the BACE-inhibitor-resistant Ab peptides produced from SH-SY5Y cellst ransfectedw ith wild-type human APP.
Results and Discussion
SeveralA b variantsh ave already been synthesized by various techniques including solid-phasep eptides ynthesis (SPPS). [17, 18] The synthesis of Ab peptides, elongated by three residues at the N-terminus, was achieved by automated solid-phase peptide synthesis on an ABI433A peptides ynthesizer.A ttempts to obtain the Ab peptides 1-3 using aW ang resin on polystyrene as as olid support, the standard FastMoc protocol from ABI, and the O-acyl-isopeptide methodf ailed.
[17c-e] However,w hen using aW ang resin on polyethylene glycol as as olid support (0.1 mmol scale) [17b] in combination with a1 0-fold excesso f Fmoc-protected amino acids (1 mmol), extendedc oupling times (35 min or 50 min), [17b, 20] and at wofold couplingf or the amino acids Ser(26) andA la (30) , the Ab peptides 1-3 were obtained as major products (see Experimental Section). After purificationb yp reparative HPLC, the Ab peptides 1-3 werei solated in good yields (Table 1) andh igh purities ( Table 2 ). The characterization of 1-3 was achieved by high-resolution ESI-MS (Table 2 , Supporting Information).
For Ab À3-38 (1)a nd Ab À3-40 (2)t he isolation after SPPS and purification by preparative HPLC was achievedw ithout any difficulty in as tandard manner.H owever,t he behavior of Ab À3-42 (3)w as very different. Some of the Ab À3-42 (3)p recipitated already during cleavage of the crude peptide from the PEG resin, indicating that more of the cleavage reagent (TFA/1,2-ethanedithiol/H 2 O/iPr 3 Si-H, 95:2:2:1) was required in order to remove the peptidec ompletelyf rom the resin. Moreover,f or HPLC the standard polar gradient proved to be unsuitable. With water as major component of the mobile phase, Ab À3-42 (3)f ormedu ndefined oligomers that weree luting from the columno ver al ong periodo ft ime. Using acetonitrile as major component in the HPLC solvent mixture for the purification process, Ab À3-42 (3)e luted from the column as as ingle peak after about 3min (Table 2 ). This procedure providedt he N-terminally elongated Ab peptides 1-3 in quantitieso f1 5-30 mg (see Experimental Section). Since the Ab peptides can misfold and give rise to aggregates leading to oligomers and fibrils, they are considered as peptides which are difficult to synthesize. [19] Therefore, the presents ynthesis of the Ab peptides 1-3 is remarkable with respecttos cale and purity.
Several N-terminallye longated peptides includingA b À3-38 (APP669-709), Ab À3-39 (APP669-710) andA b À3-40 (APP669-711) have been identified in human EDTA-blood plasma. [15] Furthermore, the ratio of Ab À3-40 to Ab 1-42 (APP669-711/Ab1-42) was proposed as anovel peripheralsurrogate biomarker of amyloid deposition in the brain of AD patients.
[15b] So far,n othingi s known about the structure of the Ab À3-40 peptide (2)a nd its potentialt of ormi nsoluble aggregates. Having the N-terminally elongated Ab peptides 1-3 available by synthesis, we first soughttoo btain insight into the overall structureo fAb À3-40 (2) in solution by pulse-field gradient (PFG)-NMR experiments, which quantify the diffusion of molecules and thus allow quantification of their hydrodynamic radius (Table3). Application of PFG-NMRm easurements to 70 mm of freshly dissolved Ab À3-40 (2)r esulted in at ranslational diffusion coefficient of 5.9 10 À7 cm 2 s
À1
. [21] On the basis of this diffusion coefficient and the Stokes-Einstein equation, ah ydrodynamic radius R h of 1.91 nm was calculated for Ab À3-40 (2) . This hydrodynamic radius is consistent with an elongated, disordered peptide of Chem.E ur.J.2016, 22,8685 -8693 www.chemeurj.org 43 amino acids. [22] Next, we investigated the two N-terminally elongated peptides,w hich end either at residue 38 (Ab À3-38 ) (1)o r4 2( A b À3-42 )( 3). Determination of the translational diffusion coefficients followed by calculation of R h ,r esulted in values of 1.79 and 1.60 nm for Ab À3-38 (1)a nd Ab À3-42 (3), respectively.D espite the longers equence, the R h of Ab À3-42 (3) was slightly smaller than that of Ab À3-38 (1)a nd Ab À3-40 (2) . This result suggests that Ab À3-42 (3)i sm ore compact than the peptides 1 and 2.
It is known that Ab 1-40 and Ab 1-42 monomers in aqueous solution are mainly unstructured, [23, 24] but exhibit at endency to adopt b-hairpin conformations. [24, 25] To gain insight into the monomeric structure of the N-terminally elongated Ab peptides at single residue level,2 Dh omonuclear proton NMR spectra were measured for freshly prepared Ab À3-38 (1), Ab À3-40 (2), and Ab À3-42 (3)s amples (ca. 70 mm,p H7.4 buffered with 20 mm sodium phosphate). The sequence-specific proton-resonance assignments of all three peptides were obtained throught he analysiso ft wo-dimensionalT OCSY and NOESY spectra.W et hen compared the TOCSY spectra of the three peptides 1-3 ( Figure 1 ). These peptides, which all start at position À3a nd only differ at the C-terminus, show an early complete overlay of their TOCSY spectra, with differencesb eing restricted to the immediate C-terminal regions ( Figure 1B ). In contrast, the chemical shifts of Ab À3-40 (2)a nd Ab 1-40 revealed some interesting differences beyondt he presence of the four additional peaks, which correspond to Lys(À2), Met(À1), Asp(1), and Ala(2) ( Figure 1A ). In particular,t he cross peaks of residues Glu(3), Phe(4), Arg(5), and to al esser extent Asp(7), Gly(9), and Tyr(10) showedp erturbations in their HN chemical shifts. Moreover,t he chemical-shift deviations were not limited to the N-terminal region of Ab,b ut also included residue Ser (26) , which points to al ong-range effect of the N-terminal elongation. Taken together,t he NMR datad emonstrate that Nterminally elongatedA b peptides are disordered in solution and that N-terminal elongation influences the backbone conformation of Ab particularly in, but not limited to, its N-terminal region.
The N-terminal region of Ab peptides is highly important for its aggregation and toxicity. [26] [27] [28] We therefore decidedt oi nvestigatet he impact of N-terminal elongation on the aggregation behavior of Ab peptides using as et of biophysical techniques. First, we performed an NMR-based monomer-consumption assay to quantify the time-dependent conversion of Ab monomers to NMR-invisible aggregates. The 1D proton NMR spectra of Ab samples were measured before and after [a] The hydrodynamic radiuso fd ioxane was used for viscosityc orrection.
[b] DSS = 4,4-Dimethyl-4-silapentane-1-sulfonic acid.
[c] Translationald iffusion coefficientsw ere obtained after gradient calibration as described previously. [21] [d] The errors represent9 5% confidence intervals. 24 ho fi ncubation in aggregation-prone conditions (37 8C, gentle stirring). The concentration of monomericA b was estimated from the NMR signal intensity using DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) as internal reference. Immediately after dissolving and before incubation, the monomeric concentrationso fA b À3-38 (1)a nd Ab À3-40 (2), as estimated by NMR spectroscopy,w ere very close to their nominal concentration, indicating that they were almostf ully solubilized ( Figure 2 ). On the other hand, the initial monomeric concentration of Ab À3-42 (3)w as approximately only 60 %o fi ts nominal concentration, reflecting its limited solubility.A fter 24 ho fi ncubation, the monomer concentrations of Ab À3-38 (1), Ab À3-40 (2), Ab À3-42 (3), and Ab 1-42 decreased to 11,6 ,1 5, and6%o ft he initial nominal concentrations, respectively ( Figure 2 ). Thus, the N-terminally elongated Ab peptides (1-3)r apidly assemble into high-molecular-weight aggregates.F urther comparison of the data for Ab À3-42 (3)a nd Ab showed that N-terminal elongation resulted in adecreased Ab peptide monomer loss. Next, we monitored if the secondary structures of the N-terminallye longated Ab peptides (1-3)w ere altered during aggregation. To this end, we used UV circulard ichroism ( Figure 3A) . Before aggregation, Ab À3-38 (1), Ab À3-40 (2), Ab À3-42 (3), and Ab 1-42 showedC Ds pectra with negative minima around 200 nm, which are characteristic for disordered polypeptide conformations. In agreement with their incomplete solubilization, evidenced by NMR spectroscopy (see above), the CD spectra of Ab À3-42 (3)a nd Ab 1-42 had less negative ellipticities at 200 nm. In addition, larger negative ellipticities were observed around2 20 nm, indicating the copresence of b-sheetrich aggregates in these samples. After 24 ho fa ggregation, all four Ab peptide variants exhibited structuralc onversion from random-coil to b-sheet ( Figure 3B ). The spectra of the aggregated Ab 1-42 ,a nd to al esser degree Ab À3-42 (3), contained strong negative peaks around2 17-219nm, indicative of extended b-sheet segments. In contrast, the CD spectra of aggregated Ab À3-38 (1), and in particular Ab À3-40 (2), showed significant red shifts of this negative peak to about 222-224 nm, suggesting that the aggregated species of theset wo Ab variants maycontain some type-II b-turn structures.
CD spectroscopy showedt hat the N-terminally elongated Ab peptides (1-3)a ggregatei nto b-sheet-rich structures. To test if the formed aggregates are amyloid fibrils, we used the amyloid-specific dye thioflavin T( ThT). The fluorescencei ntensity of ThT is loww hen in solution or bound to less stable aggregation intermediates, but is very high when bound to amyloid fibrils.
[29] All three N-terminally elongated Ab peptidev ariants exhibited ah igh rate and amounto fa ggregation (Figure 4 ). After only one hour of incubation in aggregationprone conditions as ignificant rise in ThT fluorescenceemission intensity was observedf or Ab À3-38 (1), Ab À3-40 (2), and Ab À3-42 (3). In case of Ab 1-42 ,s izeable ThT fluorescencei ntensityw as already presenti nf reshly prepared samples,i ndicating the incomplete solubilization of preformed aggregates. To further investigate the ability of N-terminally elongated Ab peptides to form amyloid fibrils, we examined the aggregated samples by electron microscopy.The peptide Ab À3-38 (1)formed fibrillaraggregates of various morphologies ( Figure 5 ). The majority of the aggregates were twisted pairs of long fibrils, while also some straight fibrils with or withoutl ateral association were observed. In the Ab À3-40 (2)s ample, fewer but longer fibrils were observed and they were predominantly twisted.I nc ontrast, both Ab À3-42 (3)a nd Ab 1-42 formed am ixture of short curved protofibrils and long twisted fibrils ( Figure 5) .
In order to evaluate the effect of N-terminal elongation on the kineticso fA b peptide fibrillara ggregation, we monitored the temporal development of ThT fluorescencei nA b x-40 and Ab x-42 peptidev ariantsi nareal-time manner.A tal ow peptide concentration of roughly 10 mm,i ncubation in mild aggregation conditions (room temperature, with agitation) resulted in ag radual increasei nt he ThT fluorescence intensities of all studied Ab peptide variants ( Figure 6 ). Table 4s ummarizes the kineticp arameters obtained from the analysis of the ThT traces according to al ogistic model. [26, 30] The rate constants suggest that the N-terminal extension by three residues promoted the fibrillar aggregation of Ab 40 and Ab 42 .I ts hould, however,b e noted that the fluorescences ignal intensities of Ab À3-40 (2)f requently rose to the maximum detection limit of the fluorimeter,h ence precluding ar eliable quantitative analysiso fi ts aggregation curves. Furthermore, the comparison of the aggregation kinetics between Ab 1-42 and Ab À3-42 (3)w as complicated by the presence of preformed aggregatesi nA b 1-42 samples as indicated by the relatively high ThT intensities at initial time points.
For further insighti nto the kinetics of Ab peptidea ggregation, we measured the rate of monomer loss during Ab peptide aggregation within the NMR tube (37 8C, withouta gita- (Figure 7 ). The comparison of the monomer-consumption profiles, especially in the initial parts, suggests that the N-terminal extension of Ab peptidesb yt hree residues did not have any significant impact on the monomerincorporation rates into previously formed aggregates.M ore rigorous kinetic experimentsa re, however,r equired before this conclusion can be confirmed. Ta ken together,o ur data indicate that N-terminally elongated Ab peptides (1-3)a re disordered in solution and rapidly form b-sheet-rich fibrillara ggregates. From the comparison of Ab À3-x with Ab 1-x we suggest that N-terminal elongation increasesthe propensity for aggregation, althought he monomer incorporation rate to preformed aggregates does not seem to be significantly affected. This is in apparent contrast with av ery recent study,i nw hich the impact of N-terminal elongation, ranging from 5-40 amino acids in length, on the aggregation kinetics of recombinant variants of human Ab 42 was investigated. [31] All of the N-terminallye xtended forms of Ab 42 under investigationw ere shown to be able to form amyloid fibrils similar to those formed from Ab 1-42 ,b ut with lower rates. The apparent discrepancyb etween these two studies may result from differences in experimental procedures such as solubilization of Ab peptidep rior to aggregation assays or the different lengths of the N-terminalextensions.
Six years ago,w er eported that treatment of SH-SY5Y cells overexpressing wild type human APP with membrane-anchored tripartite BACE1 inhibitors reducedt he overall cellular generation of Ab peptide, but at the same time led to arelative increasei ns pecific Ab peptide variants displaying isoelectric points (pI) differentf rom that of known Ab peptides starting with Asp(1), that is, pI of approximately 5.4 according to 2D-Western blot analysis.
[32] Mass spectrometry data indicated that the BACE1-inhibitor-resistant Ab peptides comprise primarily N-truncated peptides starting with Arg(5), and have ap Io fa pproximately 6.5 according to an ovel capillary isoelectric-focusing (CIEF) immunoassay. [16, 18, [33] [34] [35] In addition, am inor fraction of BACE1-inhibitor-resistant Ab peptides with ap Io fa pproximately 6.0 was observed in supernatants of APP overexpressing SH-SY5Yc ells (see Figure 2i nr ef. [18] ). AlthoughA b 2-40 / Ab 3-40 weret he most obvious candidates on the basis of their predicted isoelectricp oints, no evidence for the presence of such N-terminally truncated peptides was found using immunoprecipitationf ollowed by mass spectrometry. [18] However, when considering the occurrence of N-terminally elongated Ab variants we could now assign prominents ignals to Ab À3-38 (1) and Ab À3-40 (2), and identify the latter as the main constituent of the minor fraction of BACE1-inhibitor-resistant Ab peptides in the SH-SY5Yc ell supernatant (Figure 8 ). Given that Ab 2-40 / Ab 3-40 andA b À3-40 (2)h ave av irtually identical predicted isoelectric point, the questionarosewhether these two Ab classes can be separated by isoelectric-focusing techniques. The availability of synthetic Ab À3-40 (2)e nabled us to directly compare the isoelectric points of Ab 1-40 ,A b 2-40 ,a nd Ab À3-40 (2)b yC IEF immunoassay ( Figure 9 ). Most importantly,N -terminallye longated Ab À3-40 (2)c an be resolved from N-terminallyt runcated Ab 2-40 by isoelectric focusing due to subtle differences in net charge, providing ap owerful tool to distinguish these two Ab classes of biological and potentially pathological relevance.
Conclusion
We have developed an experimental proceduref or the selective synthesis of the N-terminallye longatedA b peptides Ab À3-38 (1), Ab À3-40 (2), and Ab À3-42 (3). In depth biophysical characterization indicatedt hat all three elongated peptides are prone to aggregate into thioflavin T-positive amyloid fibrils. The cellular production from APP appears to occur independently of BACE1 activityi nt ransfected SH-SY5Yc ells. Given their occurrence in blood,t he elongated Ab peptides starting at Val(À3) may have relevance in the context of biomarker research. It is expected that the synthetic availability of these Ab variants will advance the characterization of their potential roles under physiological or pathologicalconditions.
Experimental Section
Experimental procedure for the synthesis of the peptides 1-3: The Ab peptides were prepared by Fmoc solid-phase peptide synthesis using an ABI 433A peptide synthesizer with UV-detector. Wang resin (NovaPEG Wang resin, 0.62 mmol g À1 ,N ovabiochem) was used as solid support, HBTU (2- (1H-benzotriazol-1-yl)-1,1,3,3 tetramethyluronium hexafluorophosphate) as activation agent, and piperidine for deprotection. The resin (Wang linker on polyethylene glycol, 0.1 mmol, Novabiochem) was manually loaded with the first amino acid using MSNT (1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole) activation in order to prevent racemization. [36] For this purpose, the amino acid (20 equiv compared to the resin) was dissolved in CH 2 Cl 2 (6 mL) and THF (2-3 mL) under an argon atmosphere. 1-Methylimidazole (15 equiv compared to the resin) and fi- nally MSNT (20 equiv compared to the resin) were added. This solution was added to the resin and stirred gently for 4h.T he mixture was transferred to the synthesizer,i nw hich washing with CH 2 Cl 2 and NMP was done. Then, acetylation of potentially free Nterminal groups at the resin was achieved by treatment with Ac 2 O/ iPr 2 NEt in NMP.F or the assembly of the peptide standard cycles were used with the exception of coupling times, which were increased from 15 min to 35 min and for some amino acids to 50 min (see below). For the synthesis of the peptides 1-3,atwofold coupling was executed for Ser (26) and Ala (30) . For the following amino acids extended coupling times of 50 min were applied: Ala(2), Glu(3), Phe(4), Arg(5), His(6), His(14), Gln (15) Starting from stock solutions in DMSO(1mgmL À1 ), the indicatedA b peptides were prediluted with 20 mm bicine buffer(pH 7.6, 0.6 %C HAPS) and analyzed by CIEF immunoassay as describedpreviously. [18] The final concentrationso ft he Ab peptides in the microcapillaries were 25 ng mL Preparation of monomeric Ab peptide samples:T od issociate preformed aggregates, the Ab peptide powders were dissolved in 20 mm NaOH at 2mgmL
À1 peptide concentration and sonicated for 1min. [37] After shaking for 30 min at 4 8C, the Ab peptide solutions were exposed to ultracentrifugation (100 000 g, 4 8C, 1h). Subsequently,t he supernatants were aliquoted, flash-frozen by liquid nitrogen, and stored at À80 8Cu ntil use. Ab 1-42 was purchased from Peptide Specialty Laboratories (PSL) (Heidelberg, Germany) with apurity of more than 95 %. H-TOCSY and NOESY spectra were obtained at 5 8Cu sing mixing times of 60 and 80 ms for TOCSY and 200 and 300 ms for NOESY experiments. Peak assignments were made through standard homonuclear sequential-assignment strategy.T he PFG-NMR experiments were measured at 5 8Ca sd escribed previously. [21] Translational diffusion coefficients, obtained after gradient calibration, [21] were converted to hydrodynamic radii according to the Stokes-Einstein equation. The hydrodynamic radius of dioxane was used for the viscosity correction. For NMR-based monomer-consumption assays, 1D-1 Hspectra were measured before and after 24 ho fi ncubation under aggregation-prone conditions (37 8C, gentle stirring). The residual Ab monomer levels were quantified on the basis of NMR-signal intensities in the methyl region using DSS as internal intensity reference. For real-time monitoring of Ab monomer consumption, seeds of aggregation were added to 0.2 mg mL À1 Ab samples (pH 7.4, buffered with 50 mm sodium phosphate, containing 50 mm NaCl and 500 mm DSS), then consecutive 1D-1 Hs pectra were measured at regular intervals, while the Ab samples were incubated at 37 8C within the NMR spectrometer.T he aggregation seeds were prepared after mixing the aggregated samples of Ab À3-38 (1), Ab 1-40 , Ab À3-40 (2), Ab 1-42, and Ab À3-42 (3), spinning down the fibrils (100 000 g, 15 8C, 4h), and sonication of resuspended Ab fibrils for 30 min. The concentration ratio of seed to monomeric Ab was smaller than 1%.
Circular dichroism:C Dm easurements were performed on aJ -815 JASCO spectropolarimeter using ac uvette of 1mmp ath length. Before and after 24 ho fi ncubation under aggregation-prone conditions (37 8C, gentle stirring), the CD spectra of Ab samples (0.2 mg mL Thioflavin T( ThT) aggregation assay:A b samples (0.2 mg mL À1 , pH 7.4 buffered with 20 mm sodium phosphate) were incubated under aggregation-prone conditions (37 8C, gentle stirring). Before and after the specified time points of incubation, the ThT assays were performed by mixing 10 mLa liquots of the Ab samples with 2mLT hT solution (5 mm,p H8.0 buffered with 50 mm glycine). Fluorescence emission spectra were measured using aC ary Eclipse fluorescence spectrophotometer.T he excitation wavelength was 446 nm and the ThT emission intensities were averaged between 478 and 488 nm. For the kinetic experiments presented in Figure 6 , Ab samples (0.04 mg mL À1 in PBS, containing 25 mm ThT) were incubated in mild aggregation conditions (RT,gentle stirring) and development of the ThT fluorescence was followed in ar eal-time manner with the excitation and emission wavelengths of 446 and 482 nm and slits of 10 nm. Aggregation experiments were conducted in triplicate. The analysis of each ThT trace was performed according to the equation:dF/dt = kF(F lim ÀF). [26, 30] Electron microscopy:A b samples (0.2 mg mL À1 ,p H7.4 buffered with 25 mm HEPES) were incubated at 37 8Cw ith gentle stirring. After 24 ho fi ncubation, samples were deposited onto carboncoated copper mesh grids and negatively stained with 2% (w/v) uranyl acetate. The samples were examined using aP hilips CM 120 BioTwin transmission electron microscope (Philips Inc. Eindhoven, The Netherlands).
Cell culture, inhibitor treatment and Ab-immunoprecipitation: Cultivation of transfected SH-SY5Y cells overexpressing human wild-type APP695 with an amino-terminal Myc tag and ac arboxyterminal Flag tag and treatment with ap rototypic tripartite BACE1 inhibitor (compound 8g in ref.
[32a]) were described previously. [32a] After 72 ho ft reatment with 100 nm of tripartite inhibitor or 0.1 % DMSO (vehicle control), the conditioned media were collected and the Ab peptides immunoprecipitated as described previously. [18, 32a] Av olume of 800 mLo fc ell-culture supernatant was mixed briefly with 200 mLo fa5X IP-detergent buffer (250 mm HEPES/NaOH, pH 7.4), 750 mm NaCl, 2. Mass spectrometry:T he masses of the intact Ab peptides were determined as described previously. [18] In av acuum centrifuge, the volume of the eluted fraction from immunoprecipitation was reduced to about 10 mLa nd 0.3 mLw ere spotted onto an AnchorChip target (Bruker Daltonics, Bremen, Germany) precoated with 2-cyano-4-hydroxycinnamic acid. After drying, the samples were washed twice with (NH 4 )H 2 PO 4 (10 mm in 0.1 %T FA)a nd analyzed by mass spectrometry using an Ultraflex MALDI TOF/TOF instrument (Bruker Daltonics, Bremen, Germany) as described previously. [13, 18] Isoelectric point determination by the CIEF-Immunoassay: The isoelectric point (pI) of the peptide Ab À3-40 (2)w as compared to those of Ab 1-40 and Ab 2-40 (Ana Spec Inc.,F remont CA) by capillary isoelectric-focusing immunoassay (CIEF immunoassay) on aN anoPro 1000 device (Protein Simple) according to ar eported procedure. [18] The immunological detection shown in Figure 7w as achieved with monoclonal anti-Ab antibody WO-2 (Millipore) with a1 :50 dilution in combination with biotinylated goat-anti-mouse secondary antibody (1:100) and streptavidin-coupled horseradish peroxidase (1:100) (Protein Simple).
